CINC Revenue and Competitors
Estimated Revenue & Valuation
- CINC's estimated annual revenue is currently $31.4M per year.
- CINC's estimated revenue per employee is $165,000
Employee Data
- CINC has 190 Employees.
- CINC grew their employee count by 6% last year.
CINC's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Client Service Operations | Reveal Email/Phone |
2 | SVP | Reveal Email/Phone |
3 | VP Client Marketing | Reveal Email/Phone |
4 | VP Product | Reveal Email/Phone |
5 | Director Sales | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Director Frontline Support at CINC | Reveal Email/Phone |
8 | Senior Director - Search Engine Marketing | Reveal Email/Phone |
9 | Director Client Support | Reveal Email/Phone |
10 | Director, Demand Generation & Sales Operations | Reveal Email/Phone |
CINC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $34.2M | 222 | 46% | N/A | N/A |
What Is CINC?
Our powerful lead generation and conversion platform keeps you seamlessly engaged with your clients from Hello to Congratulations.
keywords:N/AN/A
Total Funding
190
Number of Employees
$31.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CINC News
2022-04-06 - Analysts Anticipate CinCor Pharma, Inc. (NASDAQ:CINC) Will ...
Analysts Anticipate CinCor Pharma, Inc. (NASDAQ:CINC) Will Post Earnings of -$0.50 Per Share. Posted by admin on Apr 11th, 2022.
2022-03-30 - We're Hopeful That CinCor Pharma (NASDAQ:CINC) Will Use Its Cash Wisely
Given this risk, we thought we'd take a look at whether CinCor Pharma (NASDAQ:CINC) shareholders should be worried about its cash burn.
2022-03-30 - CinCor: 2022 Data Catalysts Will Derisk The Stock
Summary. CINC's single asset is CIN-107 targeting hypertension. The company is well-funded after a solid IPO. A number of data...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 192 | 2% | N/A |
#2 | $26.3M | 199 | 62% | N/A |
#3 | $15M | 200 | 15% | N/A |
#4 | $55M | 200 | N/A | N/A |
#5 | $33M | 200 | N/A | N/A |